Date | May 2022 | Marks available | 1 | Reference code | 22M.1.HL.TZ2.37 |
Level | Higher level | Paper | Paper 1 | Time zone | Time zone 2 |
Command term | Question number | 37 | Adapted from | N/A |
Question
Cetuximab is a type of monoclonal antibody used to treat cancers of the large intestine. How are these monoclonal antibodies obtained?
A. From hybridoma cells produced by fusion of cancer cells
B. From hybridoma cells produced by fusion of tumour cells and plasma cells
C. From plasma cells produced by small mammals in response to antigens from cancer cells
D. From hybridoma cells produced by small mammals in response to antigens from cancer cells
Markscheme
B
Examiners report
[N/A]